Gram Research analysis shows that eating more flavonoids, natural plant compounds found in berries, apples, and leafy greens, is associated with significantly lower risk of cardiovascular-kidney-metabolic syndrome and related deaths. A study of 10,754 US adults found that those eating the most flavonoids had 47% lower odds of advanced disease compared to those eating the least, with benefits strongest in people under 65. The research identified a target intake of approximately 219 milligrams daily, below which each additional 50 milligrams reduced cancer death risk by 9%.
A new study of over 10,000 American adults found that eating more flavonoids, which are natural compounds found in colorful fruits, vegetables, and tea, was linked to lower rates of cardiovascular-kidney-metabolic syndrome. This condition represents a progression from metabolic problems to heart and kidney damage. The research showed that people eating the most flavonoids had about half the risk of advanced disease compared to those eating the least. Importantly, the benefits varied by disease stage: younger adults and those not taking cholesterol medications saw the strongest protective effects. The study suggests aiming for about 219 milligrams of flavonoids daily, found in foods like berries, apples, and leafy greens.
Key Statistics
A cross-sectional analysis of 10,754 US adults from 2007-2018 found that those consuming the highest amount of flavonoids had 47% lower odds of stage 2 cardiovascular-kidney-metabolic syndrome compared to those consuming the least.
According to research reviewed by Gram, in adults with early-stage cardiovascular-kidney-metabolic disease, high flavonoid intake reduced cancer mortality by 40%, while in advanced stages it reduced overall death risk by 20%.
A 2026 study of 10,754 American adults identified a flavonoid intake threshold of approximately 219 milligrams daily, below which each additional 50 milligrams reduced cancer death risk by 9%.
Research shows that anthocyanidins and flavones were the primary flavonoid types contributing to cancer mortality reduction in early disease stages, while isoflavones contributed 49.7% to all-cause mortality protection in advanced stages.
The Quick Take
- What they studied: Whether eating foods rich in flavonoids, natural plant compounds with antioxidant properties, could help prevent or slow cardiovascular-kidney-metabolic syndrome, a condition where metabolic problems gradually damage the heart and kidneys.
- Who participated: 10,754 US adults from national health surveys conducted between 2007 and 2018. Researchers tracked their diet and health status, following them for an average of 9.6 years to see who developed serious health problems or died.
- Key finding: Adults eating the most flavonoids had 47% lower odds of having advanced disease (stage 2) compared to those eating the least. The study identified a target intake of about 219 milligrams daily, below which each additional 50 milligrams reduced cancer death risk by 9%.
- What it means for you: Eating more flavonoid-rich foods like berries, apples, grapes, and leafy greens may help protect your heart and kidneys, especially if you’re under 65 or not taking cholesterol medications. However, this is observational research, so it shows association rather than proof that flavonoids directly cause the benefit.
The Research Details
Researchers examined data from 10,754 American adults participating in national health and nutrition surveys. They measured what people ate using two separate 24-hour dietary recalls, which means participants reported everything they consumed over two full days. The researchers then classified each person into one of five stages of cardiovascular-kidney-metabolic syndrome, ranging from stage 0 (no disease) to stage 4 (most advanced). They tracked participants for an average of 9.6 years to see who died and from what causes, using official death records. The analysis used advanced statistical methods to account for differences between people, such as age, smoking status, and other health factors. They also examined whether the relationship between flavonoid intake and disease followed a straight line or had a threshold effect, meaning a point where benefits plateau.
This research approach matters because it examines whether the benefits of flavonoids differ depending on how advanced someone’s disease already is. Previous studies often looked at flavonoids and heart disease in general, but this study asked whether different types of flavonoids help at different disease stages. Understanding stage-specific benefits could help doctors and patients make better dietary choices based on their current health status. The long follow-up period of nearly a decade also allowed researchers to see which dietary patterns were actually associated with living longer, not just having better test results.
The study used a large, nationally representative sample of US adults, which makes the findings more likely to apply to the general population. Researchers measured diet using validated methods and adjusted for many confounding factors that could affect results. However, because this is observational research, it cannot prove that flavonoids directly cause the benefits. People eating more flavonoids might also exercise more, smoke less, or have other healthy habits. The study also relied on people remembering what they ate, which can be inaccurate. Additionally, the researchers could not randomly assign people to eat different amounts of flavonoids, which would provide stronger evidence of cause and effect.
What the Results Show
The main finding was that higher flavonoid intake was strongly associated with lower odds of having advanced cardiovascular-kidney-metabolic syndrome. Specifically, adults in the highest quarter of flavonoid consumption had 47% lower odds of stage 2 disease compared to those in the lowest quarter. When researchers looked at death rates, they found stage-specific benefits: in people with early-stage disease (stages 1 to 2), high flavonoid intake reduced cancer deaths by 40%. In people with advanced disease (stages 3 to 4), high flavonoid intake reduced overall death risk by 20%. The study identified an important threshold of approximately 219 milligrams of flavonoids per day. Below this amount, each additional 50 milligrams of flavonoids reduced cancer death risk by 9%. Above this threshold, the benefits appeared to level off, suggesting there may be a sweet spot for flavonoid intake rather than a simple “more is better” relationship.
The researchers identified which types of flavonoids mattered most at different disease stages. For preventing cancer deaths in early-stage disease, anthocyanidins (the purple and red pigments in berries) and flavones (found in citrus and herbs) were the primary contributors. For improving survival in advanced disease, isoflavones (found mainly in soy products) appeared most important. The benefits were stronger in adults under 65 years old and in people not taking cholesterol-lowering medications. This suggests that flavonoids might work differently depending on age and whether someone is already taking medications that affect cholesterol and inflammation.
This research builds on previous studies showing that flavonoid-rich diets protect heart health. However, most earlier research examined flavonoids and heart disease as a single outcome. This study is novel because it examines whether different flavonoid types help at different disease stages and identifies a specific daily intake target of 219 milligrams. The finding that benefits plateau above this threshold differs from some earlier research suggesting a linear dose-response relationship. The stage-specific benefits also suggest that dietary recommendations might need to be tailored based on how advanced someone’s disease is, rather than using a one-size-fits-all approach.
The study has several important limitations. Because it is observational rather than experimental, it cannot prove that flavonoids directly cause the health benefits. People eating more flavonoids might also have other healthy habits that explain the results. The study relied on participants remembering what they ate during two 24-hour periods, which may not accurately represent their typical diet. The research was conducted in US adults, so findings may not apply to other populations with different diets and genetics. The study also could not determine whether specific flavonoid supplements would provide the same benefits as flavonoids from whole foods. Finally, the researchers could not account for all possible confounding factors that might influence the results.
The Bottom Line
Based on this research, aiming for approximately 219 milligrams of flavonoids daily appears to offer meaningful protection against cardiovascular-kidney-metabolic syndrome and related deaths. This can be achieved by eating colorful fruits and vegetables, particularly berries, apples, grapes, and leafy greens, along with tea and other plant-based foods. The evidence is moderate in strength because this is observational research, not a randomized trial. The benefits appear strongest in adults under 65 and those not taking cholesterol medications. These findings should complement, not replace, established heart-healthy practices like regular exercise, limiting salt and added sugars, and following medical advice.
These findings are most relevant for adults concerned about heart and kidney health, particularly those under 65 years old. People with early signs of metabolic problems or those with a family history of heart disease may benefit most from increasing flavonoid intake. Adults already taking cholesterol medications should continue their medications as prescribed and discuss dietary changes with their doctor. The findings are less directly applicable to people with advanced kidney disease, who may need to limit certain foods. Anyone with existing cardiovascular or kidney disease should consult their healthcare provider before making major dietary changes.
The study followed participants for an average of 9.6 years, so benefits likely develop gradually over months and years rather than weeks. Some benefits, such as improved blood sugar control and reduced inflammation, might appear within weeks to months of dietary changes. However, the most significant benefits for preventing advanced disease and extending lifespan likely require sustained dietary changes over years. Realistic expectations are that consistent flavonoid intake becomes part of a long-term healthy lifestyle rather than a quick fix.
Frequently Asked Questions
What foods have the most flavonoids for heart health?
Berries, apples, grapes, leafy greens, tea, and soy products contain the highest flavonoid amounts. Specifically, anthocyanidins come from purple and red berries, flavones from citrus and herbs, and isoflavones from soy. Aim for 219 milligrams daily through whole foods rather than supplements.
How much flavonoid intake do I need daily to see health benefits?
Research suggests approximately 219 milligrams daily provides meaningful protection. Below this amount, each additional 50 milligrams reduces cancer death risk by 9%. This equals roughly 3 to 4 servings of flavonoid-rich fruits, vegetables, and tea daily.
Can flavonoid supplements provide the same benefits as food sources?
This study examined flavonoids from food, not supplements, so the research cannot confirm whether supplements work the same way. Whole foods contain flavonoids plus fiber, vitamins, and other beneficial compounds that supplements lack. Food sources are recommended over supplements.
Who benefits most from eating more flavonoids?
Adults under 65 years old and those not taking cholesterol medications showed the strongest benefits in this study. People with early signs of metabolic problems or family history of heart disease may benefit most. Those with advanced kidney disease should consult their doctor first.
How long does it take to see health benefits from eating more flavonoids?
Some benefits like improved blood sugar control may appear within weeks to months. However, the most significant benefits for preventing advanced disease and extending lifespan likely require sustained dietary changes over years as part of a long-term healthy lifestyle.
Want to Apply This Research?
- Track daily flavonoid intake by logging servings of flavonoid-rich foods: berries, apples, grapes, leafy greens, tea, and soy products. Set a daily target of 3 to 4 servings of these foods and monitor whether you hit this target. The app could calculate estimated flavonoid milligrams based on portion sizes and food type.
- Start by adding one flavonoid-rich food to each meal. For example, add berries to breakfast, include a side salad with lunch, snack on an apple in the afternoon, and include leafy greens with dinner. This simple change can help reach the 219 milligram daily target without requiring major dietary overhaul.
- Track not just flavonoid intake but also related health markers over time: weight, blood pressure, blood sugar levels if available, and energy levels. Create a monthly review to assess whether consistent flavonoid intake correlates with improvements in these markers. The app could also track mood and overall wellness, as many flavonoid-rich foods have been linked to mental health benefits.
This research shows associations between flavonoid intake and health outcomes but does not prove that flavonoids directly cause these benefits. This is observational research, not a randomized controlled trial. Individual results may vary based on genetics, overall lifestyle, and existing health conditions. Anyone with cardiovascular disease, kidney disease, or taking medications should consult their healthcare provider before making significant dietary changes. This information is for educational purposes and should not replace professional medical advice. If you have concerns about your heart or kidney health, speak with your doctor about appropriate screening and treatment options.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.